EIM
CPIX icon

Essex Investment Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Essex Investment Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-34,494
Closed -$244K – 369
2017
Q3 		$244K Buy
34,494
+18,535
+116% +$128K 0.03% 332
2017
Q2 		$112K Buy
15,959
+5,014
+46% +$33.1K 0.02% 328
2017
Q1 		$76K Buy
+10,945
New +$66.3K 0.01% 339

Other funds holding CPIX

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Essex Investment Management's CPIX Position: Q4 2017 in Review

Essex Investment Management sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2017, closing a stake of 34,494 shares — an estimated $244K sold.

Essex Investment Management first reported a position in CPIX in Q1 2017 and held it in 3 quarters. The position peaked at $244K in Q3 2017. 31 funds tracked by Wall St. Rank hold CPIX as of Q4 2017.

  • Essex Investment Management reported no remaining Cumberland Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Essex Investment Management sold 34,494 Cumberland Pharmaceuticals shares in Q4 2017, an estimated $244K.
  • Essex Investment Management first reported a position in Cumberland Pharmaceuticals in Q1 2017 and held it in 3 quarters.
  • Essex Investment Management's Cumberland Pharmaceuticals position peaked at $244K in Q3 2017.
  • 31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2017.

Based on Essex Investment Management's 13F filing for Q4 2017, filed 5 Feb 2018.